Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution — RxCUI 318146
RxNorm drug concept · Semantic clinical drug
RxCUI 318146
Semantic clinical drug · SCD
● Current RxNorm concept 17 FDA products
19 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI318146
Official nameFructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG per 5 ML Oral Solution; dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG in 5 mL Oral Solution
FDA products mapped17
Package NDCs mapped19
Reported Medicaid activity (SDUD)18 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dextrose: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Dextrose is essentially glucose — sugar — given directly into a vein. In an emergency, it's used to quickly raise dangerously low blood sugar, which can happen with too much insuli...
- Specific formulations — Infant Dextrose (25%) and Dextrose (25% injection) — are FDA-approved to treat low blood sugar in newborns and infants up to 2 years old. That said, prematu...
- Is dextrose safe for my baby or newborn?
- The most common issues are high blood sugar, vein irritation or clotting at the IV site, low sodium in the blood, and infection. More serious — but less common — reactions include...
🕸️ Concept Web — How Fructose 374 MG/ML / glucose 374 MG/ML / phospho... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution
RxCUI 318146 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Fructose
4570IN -
Glucose
4850IN -
Phosphoric acid
8259IN -
Fructose / glucose / phosphoric acid
689313MIN
-
Fructose
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Emetrol
92588BN
-
Emetrol
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fructose / glucose / phosphoric acid Oral Solution
377010SCDF -
Fructose / glucose / phosphoric acid Oral Liquid Product
1162688SCDG -
Fructose / glucose / phosphoric acid Oral Product
1162689SCDG -
Fructose / glucose / phosphoric acid Oral Solution [Emetrol]
364369SBDF -
Emetrol Oral Liquid Product
1175311SBDG -
Emetrol Oral Product
1175312SBDG -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Fructose / glucose / phosphoric acid Oral Solution
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fructose 374 MG/ML
336945SCDC -
Glucose 374 MG/ML
336547SCDC -
Phosphoric acid 4.3 MG/ML
336548SCDC -
Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution [Emetrol]
809602SBD -
Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML [Emetrol]
809601SBDC
-
Fructose 374 MG/ML
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fructose 374 MG/ML
SCDC · 336945 -
Glucose 374 MG/ML
SCDC · 336547 -
Phosphoric acid 4.3 MG/ML
SCDC · 336548 -
Fructose / glucose / phosphoric acid Oral Solution
SCDF · 377010 -
Fructose / glucose / phosphoric acid Oral Liquid Product
SCDG · 1162688 -
Fructose / glucose / phosphoric acid Oral Product
SCDG · 1162689
Brand-Name Concepts
-
Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution [Emetrol]
SBD · 809602 -
Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML [Emetrol]
SBDC · 809601 -
Fructose / glucose / phosphoric acid Oral Solution [Emetrol]
SBDF · 364369 -
Emetrol Oral Liquid Product
SBDG · 1175311 -
Emetrol Oral Product
SBDG · 1175312 -
Emetrol
BN · 92588
📦 FDA Products & Package NDCs
17 products · 19 package NDCs
19 package NDCs map to RxCUI 318146 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-7080-04 | 1 BOTTLE in 1 CARTON (0363-7080-04) / 118 mL in 1 BOTTLE | Walgreen Anti Nausea Cherry Flavor | WALGREENS CO. | 2023-10-16 |
| 00363-7081-04 | 1 BOTTLE in 1 CARTON (0363-7081-04) / 118 mL in 1 BOTTLE | WALGREEN CHILDREN ANTI NAUSEA | WALGREENS CO. | 2025-12-29 |
| 00536-1302-97 | 1 BOTTLE in 1 CARTON (0536-1302-97) / 118 mL in 1 BOTTLE | Anti Nausea | RUGBY LABORATORIES | 2020-09-09 |
| 30142-0708-04 | 1 BOTTLE in 1 CARTON (30142-708-04) / 118 mL in 1 BOTTLE | Kroger Anti Nausea Cherry Flavor | KROGER COMPANY | 2020-03-31 |
| 36800-0708-04 | 1 BOTTLE in 1 CARTON (36800-708-04) / 118 mL in 1 BOTTLE | Anti Nausea Liquid | TOPCO ASSOCIATES LLC | 2018-05-14 |
| 37808-0883-04 | 1 BOTTLE in 1 CARTON (37808-883-04) / 118 mL in 1 BOTTLE | HEB Anti Nausea | HEB | 2020-04-20 |
| 41250-0495-04 | 1 BOTTLE in 1 CARTON (41250-495-04) / 118 mL in 1 BOTTLE | Meijer Anti Nausea | MEIJER DISTRIBUTION, INC. | 2020-06-29 |
| 46122-0729-26 | 1 BOTTLE in 1 CARTON (46122-729-26) / 118 mL in 1 BOTTLE | Good Neighbor Anti Nausea Cherry Flavor | AMERISOURCE BERGEN | 2023-05-01 |
| 53943-0708-04 | 1 BOTTLE in 1 CARTON (53943-708-04) / 118 mL in 1 BOTTLE | Discount Drug Mart nausea control Cherry Flavor | DISCOUNT DRUG MART | 2019-03-28 |
| 63868-0704-04 | 1 BOTTLE in 1 CARTON (63868-704-04) / 118 mL in 1 BOTTLE | Anti Nausea Liquid Cherry Flavor | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2019-04-16 |
| 63941-0708-04 | 1 BOTTLE in 1 CARTON (63941-708-04) / 118 mL in 1 BOTTLE | Best Choice Anti Nausea Cherry Flavor | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 2019-04-16 |
| 65197-0201-04 | 1 BOTTLE in 1 CARTON (65197-201-04) / 118 mL in 1 BOTTLE | Emetrol Cherry | WellSpring Pharmaceutical Corporation | 2009-06-24 |
| 65197-0201-06 | 133 mL in 1 BOTTLE (65197-201-06) | Emetrol Cherry | WellSpring Pharmaceutical Corporation | 2018-11-01 |
| 65197-0201-12 | 354 mL in 1 BOTTLE (65197-201-12) | Emetrol Cherry | WellSpring Pharmaceutical Corporation | 2025-06-15 |
| 65197-0202-14 | 1 BOTTLE in 1 CARTON (65197-202-14) / 118 mL in 1 BOTTLE | Emetrol Children Mixed Berry | WellSpring Pharmaceutical Corporation | 2023-06-01 |
| 68016-0807-04 | 1 BOTTLE in 1 CARTON (68016-807-04) / 118 mL in 1 BOTTLE | Premier Value Nausea Control Cherry Flavor | PHARMACY VALUE ALLIANCE, LLC | 2019-04-16 |
| 69842-0708-04 | 1 BOTTLE in 1 CARTON (69842-708-04) / 118 mL in 1 BOTTLE | CVS Anti Nausea Cherry Flavor | CVS PHARMACY | 2020-03-31 |
| 70000-0052-01 | 1 BOTTLE in 1 CARTON (70000-0052-1) / 118 mL in 1 BOTTLE | Anti Nausea | Cardinal Health | 2020-07-29 |
| 83324-0217-04 | 1 BOTTLE in 1 CARTON (83324-217-04) / 118 mL in 1 BOTTLE | QUALITY CHOICE Anti-Nausea | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2024-10-08 |
Observed labelers:
WellSpring Pharmaceutical Corporation (4) ·
QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) (2) ·
WALGREENS CO. (2) ·
AMERISOURCE BERGEN (1) ·
BEST CHOICE (VALU MERCHANDISERS COMPANY) (1) ·
Cardinal Health (1)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.